Cargando…

A high-throughput Anti-SARS-CoV-2 IgG testing platform for COVID-19

BACKGROUND: Serology tests for detecting the antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can identify previous infection and help to confirm the presence of current infection. OBJECTIVE: The aim of this study was to evaluate the performances of a newly developed high t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Jinwei, Chu, Eric, Zhang, Dayu, Lu, Chuanyi M., Zhang, Aiguo, Sha, Michael Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605757/ https://www.ncbi.nlm.nih.gov/pubmed/33152411 http://dx.doi.org/10.1016/j.jviromet.2020.114009

Ejemplares similares

A high-throughput microsphere-based immunoassay of anti-SARS-CoV-2 IgM testing for COVID-19 diagnostics
por: Zhang, Dayu, et al.
Publicado: (2021)

Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG
por: Sapkal, Gajanan, et al.
Publicado: (2020)

A new testing platform using fingerstick blood for quantitative antibody response evaluation after SARS-CoV-2 vaccination
por: Du, Jinwei, et al.
Publicado: (2022)

Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients
por: Liao, Baolin, et al.
Publicado: (2021)

Evaluation of Abbott anti-SARS-CoV-2 CMIA IgG and Euroimmun ELISA IgG/IgA assays in a clinical lab
por: Manalac, Justin, et al.
Publicado: (2020)

Long-Term Persistence of Anti-SARS-COV-2 IgG Antibodies
por: Yousefi, Zahra, et al.
Publicado: (2022)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG
por: Li, Fang Fang, et al.
Publicado: (2022)

Anti-SARS-CoV-2 spike IgG antibodies prevalence: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays
por: Kohmer, Niko, et al.
Publicado: (2020)

SARS-COV-2 IgG and IgM Antibodies in Cancer Patients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Hexamerization of Anti-SARS CoV IgG1 Antibodies Improves Neutralization Capacity
por: Pande, Kalyan, et al.
Publicado: (2022)

Persistence of IgG response to SARS-CoV-2
por: Duysburgh, Els, et al.
Publicado: (2021)

Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
por: Lee, Yu-Lin, et al.
Publicado: (2020)

Validation of the GSP(®)/DELFIA(®) Anti-SARS-CoV-2 IgG Kit Using Dried Blood Samples for High-Throughput Serosurveillance and Standardized Quantitative Measurement of Anti-Spike S1 IgG Antibody Responses Post-Vaccination
por: Cicalini, Ilaria, et al.
Publicado: (2022)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on
por: Korte, Wolfgang, et al.
Publicado: (2021)

Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
por: Uyoga, Sophie, et al.
Publicado: (2021)

Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection
por: Tauzin, Alexandra, et al.
Publicado: (2022)

Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2
por: Theel, Elitza S., et al.
Publicado: (2020)

Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris
por: Lo, Agnes S., et al.
Publicado: (2016)

IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity
por: Wang, Jiong, et al.
Publicado: (2022)

Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine
por: Banga Ndzouboukou, Jo-Lewis, et al.
Publicado: (2021)

High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations
por: Pučić, Maja, et al.
Publicado: (2011)

Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies
por: Beavis, Kathleen G., et al.
Publicado: (2020)

Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients
por: Crescenzo-Chaigne, Bernadette, et al.
Publicado: (2021)

Anti-SARS-CoV-2 IgG and IgM detection with a GMR based LFIA system
por: Bayin, Qiaoge, et al.
Publicado: (2021)

Seroprevalence of IgM and IgG anti-SARS-COV-2 and associated factors among agricultural workers in Colombia
por: Rodríguez, M.F., et al.
Publicado: (2022)

Verification and Comparison of Qualitative Serological Assays for Anti-SARS-COV-2 IgM and IgG Antibodies Detection
por: Štebih, Maša, et al.
Publicado: (2022)

Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome
por: Lee, Nelson, et al.
Publicado: (2006)

A Serological Analysis of the Humoral Immune Responses of Anti-RBD IgG, Anti-S1 IgG, and Anti-S2 IgG Levels Correlated to Anti-N IgG Positivity and Negativity in Sicilian Healthcare Workers (HCWs) with Third Doses of the mRNA-Based SARS-CoV-2 Vaccine: A Retrospective Cohort Study
por: Serra, Nicola, et al.
Publicado: (2023)

Anti-RBD IgA and IgG Response and Transmission in Breast Milk of Anti-SARS-CoV-2 Vaccinated Mothers
por: Trofin, Felicia, et al.
Publicado: (2022)

The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays
por: Swadźba, Jakub, et al.
Publicado: (2021)

418. Comparison of the Abbott SARS-CoV-2 IgG and DiaSorin LIASON SARS-CoV-2 S1/S2 IgG Antibody Assays
por: Schaack, Grace A, et al.
Publicado: (2020)

Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
por: Yassine, Hadi M., et al.
Publicado: (2021)

What is the long‐term clinical significance of anti‐SARS‐CoV‐2‐specific IgG?
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2020)

Estimation of anti-SARS-CoV-2 IgG titre among blood donors in Ranchi
por: Kumari, Sushma, et al.
Publicado: (2022)

Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease
por: Kiyama, Kazuhiro, et al.
Publicado: (2015)

Comparaison des tests sérologiques SARS-CoV2 Euroimmun IgG, Abbott IgG et Wantai Ac totaux
por: Petillon, C., et al.
Publicado: (2020)

IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19
por: Wang, Gang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e68f33t1dtgq9tp0k4oas61fpn